Successful treatment of infantile haemangiomas of the orbit with propranolol

Clinical and Experimental Ophthalmology

Volumn 38, Issue 6, 2010, Pages 554-559

  Li, Yi Chiao ^a   McCahon, Emma ^b   Rowe, Neil A ^b   Martin, Peter A ^a,b,c   Wilcsek, Geoffrey A ^a,c,d   Martin, Frank J ^a,b,c,e  

^a SYDNEY EYE HOSPITAL   (Australia)

^b CHILDREN S HOSPITAL AT WESTMEAD   (Australia)

^c SYDNEY CHILDREN'S HOSPITAL   (Australia)

^d PRINCE OF WALES HOSPITAL   (Australia)

^e UNIVERSITY OF SYDNEY   (Australia)

Author keywords

adrenergic antagonist; Infantile haemangioma; Propranolol

Indexed keywords

PREDNISONE; PROPRANOLOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT;

AMBLYOPIA; ARTICLE; ASTIGMATISM; CASE REPORT; CHILD; CORTICOSTEROID THERAPY; DRUG DOSE ESCALATION; DRUG EFFICACY; DRUG MEGADOSE; DRUG WITHDRAWAL; EXOPHTHALMOS; EYE EXAMINATION; EYE INJURY; EYE REFRACTION; EYE SWELLING; EYELID CLOSURE; FEMALE; HEMANGIOMA; HUMAN; INFANT; INFANT DISEASE; INFANTILE HEMANGIOMA; LAGOPHTHALMOS; LOW DRUG DOSE; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; ORBIT TUMOR; PATIENT COMPLIANCE; PRESCHOOL CHILD; TERTIARY HEALTH CARE; TREATMENT DURATION; TREATMENT OUTCOME; TREATMENT RESPONSE; VISUAL ACUITY; ORBITAL NEOPLASMS;

ADRENERGIC BETA-ANTAGONISTS; CHILD, PRESCHOOL; FEMALE; HEMANGIOMA; HUMANS; INFANT; MAGNETIC RESONANCE IMAGING; MALE; ORBITAL NEOPLASMS; PROPRANOLOL;

EID: 77955385768     PISSN: 14426404     EISSN: 14429071     Source Type: Journal    
DOI: 10.1111/j.1442-9071.2010.02327.x     Document Type: Article

References (32)

1. Kilcline C, Frieden IJ. Infantile hemangiomas: how common are they? A systematic review of the medical literature. Pediatr Dermatol 2008, 25:168-73.
2. Haggstrom AN, Drolet BA, Baselga E. Prospective study of infantile hemangiomas: clinical characteristics predicting complications and treatment. Pediatrics 2006, 118:882-7.
3. Dubois J, Milot J, Jaeger BI, McCuaig C, Rousseau E, Powell J. Orbit and eyelid hemangiomas: is there a relationship between location and ocular problems? J Am Acad Dermatol 2006, 55:614-9.
4. Bennett ML, Fleischer ABJ, Chamlin SL, Frieden IJ. Oral corticosteroid use is effective for cutaneous hemangiomas: an evidence-based evaluation. Arch Dermatol 2001, 137:1208-13.
5. Pandey A, Gangopadhyay AN, Upadhyay VD. Evaluation and management of infantile hemangioma: an overview. Ostomy Wound Manage 2008, 54:16-29.
6. Léauté-Labrès C, de la Roque ED, Hubiche T, Boralevi F, Thambo JB, Taïeb A. Propranolol for severe hemangiomas of infancy. New Engl J Med 2008, 358:2649-51.
7. Garzon MC, Drolet BA, Baselga E. Comparison of infantile hemangiomas in preterm and term infants: a prospective study. Arch Dermatol 2008, 144:1231-2.
8. Praveen V, Vidavalur R, Rosenkrantz TS, Hussain N. Infantile hemangiomas and retinopathy of prematurity: possible association. Pediatrics 2009, 123:e484-9.
9. Barnes CM, Christison-Lagay EA, Folkman J. The placenta theory and the origin of infantile hemangioma. Lymphatic Res Biol 2007, 5:245-55.
10. Chang EI, Chang EI, Thangarajah H, Hamou C, Gurtner GC. Hypoxia, hormones, and endothelial progenitor cells in hemangioma. Lymphatic Res Biol 2007, 5:237-43.
11. Phung TL, Hochman M, Mihm MC. Current knowledge of the pathogenesis of infantile hemangiomas. Arch Facial Plastic Surg 2005, 7:319-21.
12. Ritter MR, Butschek RA, Friedlander M, Friedlander SF. Pathogenesis of infantile haemangioma: new molecular and cellular insights. Expert Rev Mol Med 2007, 9:1-19.
13. Bowers RE, Graham EA, Tomlinson KM. The natural history of the strawberry nevus. Arch Dermatol 1960, 82:667-80.
14. Chung EM, Smirniotopoulos JG, Specht CS, Schroeder JW, Cube R. From the archives of the AFIP: pediatric orbit tumors and tumorlike lesions: nonosseous lesions of the extraocular orbit. Radiographics 2007, 27:1777-99.
15. Heyer GL, Millar WS, Ghatan S, Garzon MC. The neurologic aspects of PHACE: case report and review of the literature. Pediatr Neurol 2006, 35:419-24.
16. Frieden IJ, Haggstrom AN, Drolet BA. Infantile hemangiomas: current knowledge, future directions: proceedings of a research workshop on infantile hemangiomas: april 7-9, 2005 Bethesda, Maryland. Pediatr Dermatol 2005, 22:383-406.
17. Egbert JE, Paul S, Enqel WK, Summers CG. High injection pressure during intralesional injection of corticosteroids into capillary hemangiomas. Arch Ophthalmol 2001, 119:677-83.
18. Egbert JE, Schwartz GS, Walsh AW. Diagnosis and treatment of an ophthalmic artery occlusion during an intralesional injection of corticosteroid into an eyelid capillary hemangioma. Am J Ophthalmol 1996, 121:638-42.
19. Ezekowitz RA, Mulliken JB, Folkman J. Interferon alfa-2a therapy for life-threatening hemangiomas of infancy. New Engl J Med 1992, 326:1456-63.
20. Sarihan H, Mocan H, Yildiz K, Abes M, Akyazici R. A new treatment with bleomycin for complicated cutaneous hemangioma in children. Eur J Pediatr Surg 1997, 7:158-62.
21. Enjolras O, Breviere GM, Roger G. Vincristine treatment for function- and life-threatening infantile hemangioma. Archive Pediatr 2004, 11:99-107.
22. Hurvitz SA, Hurvitz CH, Sloninsky L, Sanford MC. Successful treatment with cyclophosphamide of life threatening diffuse hemangiomatosis involving the liver. J Pediatr Hematology Oncol 2000, 22:527-32.
23. Frei-Jones M, McKinstry RC, Perry A, Leonard JR, Park TS, Rubin JB. Use of thalidomide to diminish growth velocity in a life-threatening congenital intracranial hemangioma. J Neurosurg: Pediatr 2008, 2:125-9.
24. Jarvi K, Roebuck DJ, Sebire NJ. Successful treatment of extensive infantile hemangiomatosis of the small bowel in a 3-month-old with thalidomide and somatostatin analog. J Pediatr Gastroenterol Nutr 2008, 46:593-7.
25. Levi M, Schwartz S, Blei F. Surgical treatment of capillary hemangiomas causing amblyopia. J AAPOS 2007, 11:230-4.
26. Aldave AJ, Shields CL, Shields JA. Surgical excision of selected amblyogenic periorbital capillary hemangiomas. Ophthalmic Surg Laser 1999, 30:754-7.
27. Victor S, Ryan S. Drugs for preventingmigraine headaches in children. Cochrane Database Syst Rev 2003, CD002761
28. Frobel AK, Hulpke-Wette M, Schmidt KG, Läer S. Beta-blockers for congestive heart failure in children. Cochrane Database Syst Rev 2009, CD007037
29. Robinson RF, Nahata MC, Batisky DL, Mahan JD. Pharmacologic treatment of chronic pediatric hypertension. Paediatric Drugs 2007, 41:1181-90.
30. Sans V, de la Roque ED, Berge J. Propranolol for severe infantile hemangiomas: follow-up report. Pediatrics 2009, 124:e423-31.
31. Tvedskov JF, Thomsen LL, Thomsen LL. The effect of propranolol on glyceryltrinitrate-induced headache and arterial response. Cephalalgia 2004, 24:1076-87.
32. Bellissant E, Annane D, Thuillez C, Giudicelli JF. Comparison of the effects of dilevalol and propranolol on systemic and regional haemodynamics in healthy volunteers at rest and during exercise. Eur J Clin Pharmacol 1994, 47:39-47.